-
FRISQ to conduct a rights issue of SEK 12 million
As previously communicated, The Board of Directors of FRISQ Holding AB (“FRISQ” or the “Company”) has decided, based on authorization by a shareholders’ meeting, to conduct a new share issue of a maximum 11,988,693 shares at a subscription price of one (1) SEK per share, with preferential rights for the Company’s existing shareholders (the “Rights …
More -
Additional information regarding FRISQ Holding’s directed new issue of shares
FRISQ Holding AB has, as previously been communicated, carried out a directed new issue of 18,150,000 shares at the price of one (1) SEK per share. The share issue was to 80% subscribed by existing shareholders with Nordica Life Insurance for its customers (8 MSEK) and Nordic Cross Asset Management AB (1.5 MSEK) as largest …
More -
Business update from FRISQ
FRISQ Holding AB has, as previously communicated, carried out a directed share issue of 18,150,000 shares at the issue price of one (1) SEK per share. This new share issue will be followed up by a rights issue to all shareholders of a maximum of 13.8 million shares at the same issue price. The details …
More -
FRISQ Holding AB decides on a new share issue to secure the company’s financial position
FRISQ Holding AB (“FRISQ” or “the Company”) has in a previous press release announced its intention to decide on a new share issue. FRISQ has now secured a new share issue. As the board of FRISQ didn’t receive a signed and binding share transfer agreement from Tempest SPV Ltd on Monday, the Board has, with the …
More -
FRISQ Holding AB intends to decide on a new share issue to secure the company’s financial position
As the board of FRISQ Holding AB (hereinafter "Frisq" or "the Company") did not receive a signed and binding share purchase agreement from Tempest SPV Ltd on Monday, the board intends to decide on a new share issue with the authorization given at the Extraordinary General Meeting. The purpose of the new share issue is …
More -
Report Q4 and Full Year 2021
January-December 2021 CEO StatementThe hope that healthcare could look to the time after the pandemic, including the necessary innovation work needed, were once again sharply shaken when the Omicron variant created a new wave in the last quarter of 2021 . We are therefore extra proud of what we have managed to achieve despite these …
More